Skip to content

The effect of topical lidocaine cream on the efficacy of botulinum toxin injection

The effect of lidocaine ointment applied externally on the therapeutic efficacy of botulinum toxin injection in the forehead: A self-controlled, randomized, blind study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124456
Enrollment
Unknown
Registered
2026-05-12
Start date
2026-05-12
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

forehead wrinkle

Interventions

control group:NA
Intervention group:Application of lidocaine cream externally

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.18 to 65 years old (inclusive of both upper and lower limits), open to both men and women; 2.When raising the eyebrows, there are clearly visible wrinkles on the forehead: the FWS (Facial Wrinkle Score Scale) score is >=1 point. 3.Understand the treatment of botulinum toxin and voluntarily participate in this trial;

Exclusion criteria

Exclusion criteria: 1.Having received botulinum toxin treatment within the past six months; 2.Previous treatment with botulinum toxin was ineffective or resulted in an allergic reaction; 3.Penicillin allergy; 4.Have severe chronic diseases and are currently taking medications that are contraindicated when using botulinum toxin, such as muscle relaxants or commonly used antibiotics. 5.Patients with myasthenia gravis and ptosis of the upper eyelid; 6.Pregnant and lactating women; 7.Currently participating in other clinical trials, or having been involved in clinical trials that affect this study for less than 3 months. 8.Previously undergone forehead wrinkle removal surgery with impaired frontal muscle movement, or damage to the frontal branch of the facial nerve resulting in inability to raise the eyebrows normally; 9.Unable to cooperate with regular follow-ups; 10.Other situations judged by the researchers as not meeting the inclusion criteria;

Design outcomes

Primary

MeasureTime frame
Improvement rate;

Secondary

MeasureTime frame
Duration of botulinum toxin treatment on both sides;Changes in perspiration;Changes in skin pores;

Countries

China

Contacts

Public Contactxie yun

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

amiyayun@qq.com+86 21 53314074

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026